Agilent Technologies announced this week that it has named Nick Roelofs vice president and general manager of its Life Sciences Solutions Unit. Roelofs will be responsible for product profit and loss of the business group that includes microarrays, liquid chromatographs, microfluidics, mass spectrometers, capillary electrophoresis, and informatics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.